To further study whether the AKT signaling pathway was necessary for miR-129-2-mediated suppression of HCC migration and invasion, we transfected miR-129-2-overexpressing cells with pmyt-AKT (dominant-active AKT) or pcDNA3.1. The gene discussed is AKT1; the disease is hepatocellular carcinoma.